Skip to content

APR Femoral Hip Component

by Intermedics Orthopedics

510(k) K930812

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK930812 Date17 Nov 1993ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JDI
Device Class
Class II
Regulation
21 CFR Part 888.3350
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The APR Femoral Hip Component is a prosthetic device designed for use in total hip arthroplasty. It is classified as a femoral component for hip replacement, intended to replace the damaged or diseased femoral head and neck with a durable, load-bearing implant. Constructed to interface with acetabular components, it is engineered to restore joint function and mobility in patients with degenerative joint disease, fractures, or other conditions requiring hip arthroplasty.

This device is supplied as a single-use, sterile implant and is regulated under FDA 510(k) clearance (K930812) as a Class II Orthopedic device. It is intended for surgical use in orthopedic settings and must be handled using aseptic techniques. The component is available in various sizes to accommodate different patient anatomies, with specifications detailed in the original submission. No additional regulatory markings beyond the FDA clearance are stated in the provided data.

Other devices from Intermedics Orthopedics

See all devices from Intermedics Orthopedics →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the APR Femoral Hip Component used for?

    The APR Femoral Hip Component is designed specifically for total hip arthroplasty, replacing the damaged or diseased femoral head and neck in patients suffering from degenerative joint disease, fractures, or other conditions requiring hip replacement. It interfaces with acetabular components to restore joint function and improve mobility, providing a durable, load-bearing solution for long-term use.

  • Is the APR Femoral Hip Component single-use or reusable?

    The APR Femoral Hip Component is supplied as a single-use, sterile implant. This ensures patient safety by preventing cross-contamination and maintaining sterility during surgical procedures, adhering to aseptic technique requirements in orthopedic settings.

  • What sizes are available for the APR Femoral Hip Component?

    The APR Femoral Hip Component comes in various sizes to accommodate different patient anatomies. Exact specifications for sizing are detailed in the original FDA submission and should be referenced during preoperative planning to ensure proper fit and function.

  • How should the APR Femoral Hip Component be stored?

    Since the APR Femoral Hip Component is sterile and single-use, it must be stored in its original packaging under clean, dry conditions to preserve sterility. Avoid exposure to moisture, extreme temperatures, or direct sunlight, and follow manufacturer guidelines to maintain integrity until surgical use.

  • What regulatory approval does the APR Femoral Hip Component hold?

    The APR Femoral Hip Component holds FDA 510(k) clearance (K930812) as a Class II Orthopedic device, classified as substantially equivalent under traditional review. This approval confirms its compliance with U.S. regulatory standards for use in total hip arthroplasty procedures.